WHO ICTRP trial
Prophylactic effect of tranexamic acid capsule in controlling epistaxis
IRCT20180425039418N7 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20180425039418N7 |
|---|---|
| Public title | Prophylactic effect of tranexamic acid capsule in controlling epistaxis |
| Scientific title | Evaluation of prophylactic effect of tranexamic acid capsule on nasal hemorrhage in patients with epistaxis |
| Primary sponsor | Zahedan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Epistaxis. Epistaxis;R04.0 |
| Interventions | Intervention 1: Intervention group: For 50 patients, drops of NaCl and vitamin A ointment with 500 mg tranexamic acid were administered every 8 hours a week. Intervention 2: Control group: For 50 patients, drops of NaCl and vitamin A… |
| Registration date | Jul 10, 2019 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: